Mpox study: biology, outcome, transmission, and spread
Part of Infections clinical trials.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being tested for mpox at a participating testing center.
- You or your representative agree to join the study.
- If you are under 18, you cannot have genital, anal, or semen samples taken, nor follow-up blood draws.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study is testing a new way to diagnose mpox (formerly monkeypox) using a sample from your skin sores. If you have symptoms that look like mpox, this test might help confirm the diagnosis quickly.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This study looks at how well your immune system remembers the mpox virus after you've been infected. It may help researchers understand protection against future infections.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.